The US Food and Drug Administration (FDA) has granted clearance to medical equipment firm Toshiba Medical’s new cardiovascular ultrasound Aplio i900.
19 March 2017
3 October 2016
Xeltis reports successful heart valve implantation for cardiovascular restoration in pediatric patients
Swiss-Dutch clinical-stage medical device company Xeltis has announced the successful implantation of three pediatric patients with its heart valve that allows cardiovascular restoration.
15 September 2016
With a vision to develop intelligent diabetes management systems, French pharmaceutical company, Sanofi SA has partnered with Verily Life Sciences to form a new joint venture company named Onduo in...
29 August 2016
Royal Philips has unveiled the latest version of its next-generation Cardiovascular Image and Information Management System, IntelliSpace Cardiovascular 2.1 for diagnostic imaging.
28 January 2016
Boston Scientific and Accenture develop new digital health solution for chronic cardiovascular diseases
US-based medical device firm Boston Scientific, along with Accenture, has developed a new cloud-based and data-driven digital health solution, Advantics Care Pathway Transformation, to help improve patient outcomes and reduce...
8 February 2015
Canada-based Response Biomedical has expanded the scope of its agreement with China-based Shanghai Elite Biotech to distribute its cardiovascular portfolio of RAMP products.
3 November 2014
US-based medical device firm Cardiovascular Systems (CSI) has received CE Mark for its Stealth 360º Orbital Atherectomy System (OAS), which is indicated to treat patients who suffer from peripheral arterial...
12 June 2014
US-based Cardiovascular Systems (CSI) has started enrolling patients in its coronary orbital atherectomy system trial (COAST), designed to evaluate safety and efficacy, as well as economic outcomes, of CSI’s new...
11 March 2014
Cardiovascular Systems has obtained US Food and Drug Administration (FDA) clearance for a new size of its Diamondback 360 peripheral orbital atherectomy system (OAS), designed for treating peripheral arterial disease...
23 October 2013
US-based Cardiovascular Systems has received pre-market approval (PMA) from the US Food and Drug Administration (FDA) to market its Diamondback 360 coronary orbital atherectomy system (OAS), designed to treat severely...